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1. Introduction 
The number of human globin genes has been 
investigated in the last years by several approaches. 
The direct isolation and study of the DNA [ 1,2] is 
surely the best, but is possible only in a very limited 
number of cases. A more often used possibility is to 
investigate the various polypeptide chains which are 
the final product of the expression of the genes. 
From all the data, it is concluded that the P-chain is 
under the control of one single gene. 
Conversely, the existence of at least two y-genes 
has been demonstrated by the different primary 
structures and confirmed by all subsequent genetic 
studies [3,4]. 
The problem of the number of a-chain genes is 
much more controversial and not entirely solved. 
There are many arguments in favour of the existence 
of two genes [5], both from direct estimation in 
cases of cu-thalassemia [2] and from the study of the 
Hungarian probands carrying two a-mutants 
together with normal Hb A [6]. 
Nevertheless the data concerning Hb Tongariki 
[7,8] do not seem to be compatible with this 
hypothesis, equally in heterozygotes and homo- 
zygotes, and favour the existence of a unique o-gene. 
Furthermore the percentage of o-variants found is 
often closer to 30 or 40 per cent than the expected 
25 per cent. The existence of an associated 
cu-thalassemia h s been postulated and allows a possible 
explanation in almost every case [9]. On the other 
hand, the varying percentages of the o-mutant Hb G 
Philadelphia in the same family has suggested a
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heterogenous distribution of one o-gene and two 
o-genes [lo] . No hypothesis has been convincingly 
confirmed by biosynthetic studies. 
An a-mutant Hb J Mexico (II 54 Gln + Glu is 
relatively frequent in a part of the Algerian popula- 
tion, and this in large families. From these data and 
biosynthetic studies, we bring forward arguments 
supporting the model proposed by Rucknagel 
[lo, 1 l] , that the chromosomes bear either one or 
two CY -chain genes, at least in this population. 
2. Materials and methods 
The abnormal haemoglobin was studied in 32 
healthy subjects belonging to 7 families. From a partial 
investigation, it was found to be present in 0.5 per 
cent of the population in a limited area, 100 km south 
of Algiers. The haematological data were normal. In 
some cases the abnormal haemoglobin was associated 
with a /3-thalassemia. The primary structure has been 
checked by the usual techniques in at least one 
patient of each family. 
The percentage of the abnormal hemoglobin was 
estimated by several methods. Elution from cellulose 
acetate strips and spectrophotometric estimation were 
performed at least in triplicate for all the subjects. It 
was in several cases confirmed by DEAE-Sephadex 
chromatography and isoelectric focusing followed by 
densitometric scanning. A possible contamination by 
Hb A3 was excluded. 
For biosynthetic studies, the reticulocyte counts 
were increased by centrifugation. The cells were 
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incubated according to Lingrel and Borsook [ 121 with 
slight modifications, using [3H]leucine as a marker. 
Globin was prepared from hemoglobin by acid acetone 
precipitation and polypeptide chains were separated 
[ 131. The 60 min incubation lysates were passed 
through a molecular sieve in order to identify possible 
precursors. The radioactivity was determined by 
liquid scintillation counting. 
3. Results and discussion 
3.1. Expression of the variant Hb J 
On plotting the results of the estimations made 
by the elution technique, the bimodality of the 
distribution is apparent with two maxima, one at 
31 per cent and the second around 40 per cent 
(fig. 1). These results agree with those given by Rucknagel 
studying Hb G Philadelphia, and the bimodality is 
more clearcut. 
In each family the distribution was either bimodal, 
or unimodal around 30 per cent. 
3.2. Biosynthetic studies 
Only three subjects of one family could be fully 
investigated (table 1). Two heterozygotes (I and II) 
belonged to groups described above. A third subject 
(III) was doubly heterozygote for Hb J and /3- 
thalassemia. 
In the subjects I and II, the biosynthetic ratio /3/a 
was balanced. In these cases we did not find evidence 
for cr-thalassemia. In the third case, the ratio p/a was 
0.5 due to the fl-thalassemia. In the three patients, 
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Fig.1. BimodaI distribution of the percentages of Hb J in 
heterozygotes. Each determination was done in triplicate. 
of abnormal chain synthesized and the percentage 
expressed in the peripheral blood. This difference 
was found (table 1) equally with the thalassemic and 
the non-thalassemic subjects.This result supports the 
argument that the thalassemic gene does not interfere 
with the expression of the d-gene. 
c I,’ 
In one patient with the higher percentage of Hb J, 
the synthetic ratio cwJ/crA was constant (0.85) through- 
out the various times of incubation, suggesting a slight 
defect of d-chain synthesis. 
When plotting the specific activity ratio of both 
o-chains S.A. aJ/S.A. CV* as a function of the incuba- 
tion time, a moderate increase suggested a small but 
discrete destruction of the abnormal chain [ 141. This, 
Table 1 
‘H Incorporation into the various chains 
Patients Total activity (cpm) 
lY* P ,J 
Total activity Total activity Peripheral 
ratio ratio blood 
P o HbJ ___- 
A J 01 +o dtaJ HbA+J 
I 9208 5163 2904 1.14 0.36 0.26 
II 16 616 7997 6881 1.12 0.46 0.36 
III 55 600 72 546 39 062 0.50 0.35 0.25 
After a 60 min incubation, the total activity ratio shows an unbalanced synthesis for the J 
pthalassemic patient (III). The synthesis is balanced for both heterozygotes A J. 
The oJ synthesis is always higher than the expression in the peripheral blood. 
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together with the slightly defective synthesis, could 
explain the difference between the percentages of 
chains synthesized and the expression in the red cells. 
By molecular filtration, a minimal amount of 
precursors was found in the non-thalassemic subjects. 
In the thalassemic one, two peaks corresponding to 
dimers and monomers amounted to more than half 
of the synthesized subunits. They were pure o-chains, 
o* and crJ, the proportion of both components being 
the same in the precursors as in the whole hemoglobin. 
Thus even when the P-chains are quantitatively 
limited, they do not associate preferentially with the 
normal a-chains. 
3.3. Genetic interpretation 
Our results favour the model proposed by 
Rucknagel, with a heterogenous distribution of 
one o-gene and two a-gene chromosomes. This would 
explain both the bimodal distribution and the 
biosynthetic data. 
A percentage of 40 per cent Hb J would correspond 
to one a-gene on each chromosome, a percentage of 
30 per cent to the abnormal gene on one chromosome 
and a duplicated normal gene on the other (fig.2). 
This would postulate the existence of subjects with 
four genes. It is possible that in the ethnic group 
studied, the mutation exists only on the non-duplicated 
gene, and that the third model with Hb J below 25 per 
cent cannot be encountered. 
HtiHI 40 s.cml 
Fig.2. Heterogenous distribution of one and two o-genes. 
Only the two first patterns have been found for Hb J in 
Algeria. 
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